novo nordisk oral glp-1 Nordisk's drug didn't work on Alzheimer's as hoped, but don't call it a failure Novo Nordisk expands oral GLP-1

Description

### Funding Statement SDL and AC were supported by the National Science Foundation (Grant Nos.\ CAREER DMS-1944574 and DMS-2325258) ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained

Emily] on Amazon.com

The clinical data is real

Their Ophthalmic Complications Explained #DoctorSpeak New diabetes and weight-loss drugs like Semaglutide and Tirzepatide (Commonly known as Ozempic, Wegovy)...

In this Review, the authors discuss the potential effects of GLP-1 receptor agonists on the incidence, disease activity and progression of various forms of arthritis, as well as practical considerations for their use in this context.